Xenogeneic delivery of therapeutic products using transient immunosuppression.
Park
Kinam
K
D000818:Animals; D004921:Erythropoietin / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D032446:Myoblasts / Q000637:transplantation*; D051381:Rats; D011916:Rats, Inbred F344; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D007166:Immunosuppressive Agents; D004921:Erythropoietin; D016559:Tacrolimus